GDC-0994

CAS No. 1453848-26-4

GDC-0994 ( RG-7842 )

Catalog No. M11952 CAS No. 1453848-26-4

GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 69 In Stock
10MG 87 In Stock
25MG 158 In Stock
50MG 267 In Stock
100MG 399 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GDC-0994
  • Note
    Research use only, not for human use.
  • Brief Description
    GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
  • Description
    GDC-0994 is a potent, orally available ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
  • Synonyms
    RG-7842
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK1; ERK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1453848-26-4
  • Formula Weight
    440.86
  • Molecular Formula
    C21H18ClFN6O2
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 87 mg/mL (197.79 mM); DMSO: 87 mg/mL (197.79 mM)
  • SMILES
    O=C1C=C(C2=NC(NC3=CC=NN3C)=NC=C2)C=CN1[C@@H](C4=CC=C(Cl)C(F)=C4)CO
  • Chemical Name
    (S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. AACR2014. Abstract.
molnova catalog
related products
  • Tauroursodeoxycholic...

    Tauroursodeoxycholic acid (TUDCA) is a neuroprotective bile conjugate; inhibits nuclear factor-kappa B (NF-κB) activation in glial cells.

  • Isomeranzin

    Isomeranzin has anti-inflammatory activity, it suppresses inflammation by inhibiting M1 macrophage polarization through the p65, NF-κB and ERK pathway.

  • ERK5-IN-1

    ERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).